Analyst
Wells Fargo
Equibles does not estimate personal net worth.
Orpheus is recorded as Analyst at Wells Fargo. Orpheus has spoken on 2 earnings calls across 2 companies, most recently for Amphastar Pharmaceuticals, Inc. on November 5, 2026. Those appearances were for Amphastar Pharmaceuticals, Inc. (AMPH) and Alkermes plc. (ALKS). The companies whose calls Orpheus spoke on are classified in the Healthcare sector.
“There seems to have been a small delay in the AMP 005 and 017 filings from the first half of 2017 to the second half. Do you want us to understand what drove that?”
“I had another question on oxidase plus orexins. You've tried this as complementary, and you've also heard similar feedback from my KOLs. With that in mind, could you remind us of your plans to generate data of an orexin agonist in combination with an oxidase?”
Wells Fargo
Analyst
Transcript header (unverified)
Drug Manufacturers - Specialty & Generic · Healthcare
ALKS
Drug Manufacturers - Specialty & Generic · Healthcare
